Do you want to read an article? Please log in or register.
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19
Viral Infections, Non-HIV
Related content
Viral Infections, Non-HIV
Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID-19: A Retrospective Italian Cohort Study of 43,000 Patients
Drug Saf.
Trifirò G, Massari M, Da Cas R, Menniti Ippolito F, Sultana J, Crisafulli S, Giorgi Rossi P, Marino M, Zorzi M, Bovo E, Leoni O, Ludergnani M, Spila Alegiani S, ITA-COVID-19: RAAS inhibitor group.
doi: 10.1007/s40264-020-00994-5.
Viral Infections, Non-HIV
Renin-Angiotensin system inhibitors effect before and during hospitalization in COVID-19 outcomes: final analysis of the international HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) Registry
Am Heart J
Núñez-Gil IJ, Olier I, Feltes G, Viana-Llamas MC, Maroun-Eid C, Romero R, Fernández-Rozas I, Uribarri A, Becerra-Muñoz VM, Alfonso-Rodriguez E, García-Aguado M, Elola J, Castro-Mejía A, Pepe M, Garcia-Prieto JF, Gonzalez A, Ugo F, Cerrato E, Bondia E, Raposeiras S, Mendez JLJ, Espejo C, Masjuan ÁL, Marin F, López-Pais J, Abumayyaleh M, Corbi-Pascual M, Liebetrau C, Ramakrisna H, Estrada V, Macaya C, HOPE COVID-19 investigators (Cols appendix).
doi: 10.1016/j.ahj.2021.04.001
Viral Infections, Non-HIV
Association between Renin-Angiotensin-Aldosterone system inhibitor use and COVID-19 Hospitalization and death: A 1,4 million patient Nation-Wide registry analysis
Eur J Heart Fail
Savarese G, Benson L, Sundström J, Lund LH
doi: 10.1002/ejhf.2060
Viral Infections, Non-HIV
Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19
N Engl J Med.
Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G
doi: 10.1056/NEJMoa2006923.
Viral Infections, Non-HIV
Is There an Association Between COVID-19 Mortality and the Renin-Angiotensin System-a Call for Epidemiologic Investigations
Clin Infect Dis.
Hanff TC, Harhay MO, Brown TS, Cohen JB, Mohareb AM
doi: 10.1093/cid/ciaa329.
Viral Infections, Non-HIV
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers Use and COVID-19 Infection Among 824,650 Patients with Hypertension from a US integrated Healthcare System
J Am Heart Assoc
An J, Wei R, Zhou H, Luong TQ, Gould MK, Mefford MT, Harrison TN, Creekmur B, Lee MS, Sim JJ, Brettler JW, Martin JP, Ong-Su AL, Reynolds K
doi: 10.1161/JAHA.120.019669
Viral Infections, Non-HIV
Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
JAMA.
Fosbøl EL, Butt JH, Østergaard L, Andersson C, Selmer C, Kragholm K, Schou M, Phelps M, Gislason GH, Gerds TA, Torp-Pedersen C, Køber L
doi: 10.1001/jama.2020.11301.
RECOMMENDED
Viral Infections, Non-HIV
Antihypertensive Drugs and COVID-19 Risk: A Cohort Study of 2 Million Hypertensive Patients
★ 3
Recommended by
Prof. Dr Isabella Sudano, Faculty Member
Hypertension
Semenzato L, Botton J, Drouin J, Baricault B, Vabre C, Cuenot F, Penso L, Herlemont P, Sbidian E, Weill A, Dray-Spira R, Zureik M
doi: 10.1161/HYPERTENSIONAHA.120.16314
Viral Infections, Non-HIV
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
JAMA Intern Med.
Grasselli G, Greco M, Zanella A, Albano G, Antonelli M, Bellani G, Bonanomi E, Cabrini L, Carlesso E, Castelli G, Cattaneo S, Cereda D, Colombo S, Coluccello A, Crescini G, Forastieri Molinari A, Foti G, Fumagalli R, Iotti GA, Langer T, Latronico N, Lorini FL, Mojoli F, Natalini G, Pessina CM, Ranieri VM, Rech R, Scudeller L, Rosano A, Storti E, Thompson BT, Tirani M, Villani PG, Pesenti A, Cecconi M, COVID-19 Lombardy ICU Network.
doi: 10.1001/jamainternmed.2020.3539.